Agatolimod

DB15018InvestigationalNucleic Acid Based Therapies

Agatolimod is under investigation in clinical trial NCT00471471 (Vaccine Therapy in Treating Patients With Recurrent Stage III or Stage IV Melanoma That Cannot Be Removed by Surgery).

Mechanism: Pharmacologically active on Toll-like receptor 9
Curator reviewed
Also known as: PF-3512676 free acid
Code names: CPG-10104

Resolves to

Compound

UNII5V336PV3HGCAS207623-20-9

Clinical / RWD

RxNorm2665622

Targets

Q9NR96TLR9

What you can answer from here — as of July 17, 2026

1Protein targetEach mapped to UniProt, with action and pharmacological action

Listed above

39Clinical trialsPhase, status and sponsor resolved per trial

3+ReferencesStructured and connected to the statements they support

Which drugs share a target with Agatolimod, and which of those have an active Phase 3 trial?

Answer this in Biopharma OS Sign in to your account

Create a free account or log in to explore the full data card.

Create Account